|
TSLA
|
Consumer Cyclical |
Daiwa Capital |
Downgrade
|
Outperform
→
Neutral
|
—
|
$1.4T
|
$100.87
|
-6.4%
|
-6.3%
|
+8.6%
|
-4.1%
|
+1.5%
|
-0.8%
|
|
INTC
|
Technology |
BofA Securities |
Downgrade
|
Buy
→
Neutral
|
—
|
$538.0B
|
$60.40
|
-13.7%
|
-16.2%
|
-2.0%
|
-0.7%
|
-2.4%
|
-0.2%
|
|
INTC
|
Technology |
Roth Capital |
Downgrade
|
Buy
→
Neutral
|
—
|
$538.0B
|
$60.40
|
-13.7%
|
-16.2%
|
-2.0%
|
-0.7%
|
-2.4%
|
-0.2%
|
|
INTC
|
Technology |
Bernstein |
Downgrade
|
Market Perform
→
Underperform
|
—
|
$538.0B
|
$60.40
|
-13.7%
|
-16.2%
|
-2.0%
|
-0.7%
|
-2.4%
|
-0.2%
|
|
INTC
|
Technology |
Barclays |
Downgrade
|
Equal Weight
→
Underweight
|
—
|
$538.0B
|
$60.40
|
-13.7%
|
-16.2%
|
-2.0%
|
-0.7%
|
-2.4%
|
-0.2%
|
|
INTC
|
Technology |
Deutsche Bank |
Downgrade
|
Buy
→
Hold
|
—
|
$538.0B
|
$60.40
|
-13.7%
|
-16.2%
|
-2.0%
|
-0.7%
|
-2.4%
|
-0.2%
|
|
INTC
|
Technology |
Northland Capital Markets |
Downgrade
|
Market Perform
→
Underperform
|
—
|
$538.0B
|
$60.40
|
-13.7%
|
-16.2%
|
-2.0%
|
-0.7%
|
-2.4%
|
-0.2%
|
|
ENTG
|
Technology |
Craig-Hallum |
Downgrade
|
Buy
→
Hold
|
—
|
$18.9B
|
$69.65
|
-3.2%
|
-2.6%
|
+2.5%
|
-0.5%
|
+2.8%
|
+1.5%
|
|
TSCO
|
Consumer Cyclical |
Morgan Stanley |
Downgrade
|
Overweight
→
Equal Weight
|
—
|
$16.6B
|
$29.20
|
-1.8%
|
+0.4%
|
-2.4%
|
+0.0%
|
+1.7%
|
-1.4%
|
|
ICLR
|
Healthcare |
BofA Securities |
Downgrade
|
Buy
→
Neutral
|
—
|
$9.4B
|
$189.06
|
-0.0%
|
-2.1%
|
+0.8%
|
-0.5%
|
-0.8%
|
+0.5%
|
|
BRBR
|
Consumer Defensive |
Evercore ISI |
Downgrade
|
Outperform
→
In Line
|
—
|
$1.2B
|
$20.36
|
-3.0%
|
-8.0%
|
+3.3%
|
+0.0%
|
+0.9%
|
-0.1%
|
|
ABUS
|
Healthcare |
Baird |
Downgrade
|
Outperform
→
Neutral
|
—
|
$837M
|
$6.20
|
+28.7%
|
-20.0%
|
-9.9%
|
-10.1%
|
+0.5%
|
+6.4%
|
|
XRX
|
Technology |
JP Morgan |
Downgrade
|
Neutral
→
Underweight
|
—
|
$329M
|
$16.81
|
-3.6%
|
-6.9%
|
+1.1%
|
-3.9%
|
+4.3%
|
+2.9%
|